Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05890820
Other study ID # E-53610172-799-207700439
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 30, 2023
Est. completion date October 30, 2023

Study information

Verified date May 2023
Source Ankara Ataturk Sanatorium Training and Research Hospital
Contact Mustafa Özgür Cirik Cirik, Assoc Prof
Phone 903123677235
Email dr.ozgurr@hotmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Preoperative evaluation of nutritional status in geriatric patients with lung cancer and implementation of these practices in elective patients are very important in terms of reducing postoperative complications and accelerating hospital discharge. For this purpose, many nutritional assessments and measurements are used. Our aim in this study was to evaluate the relationship between preoperative nutritional status and postoperative pulmonary complications in patients undergoing thoracic surgery for geriatric lung cancer.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date October 30, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Patients over 65 years of age - Lung Cancer - Patients undergoing thoracic surgery Exclusion Criteria: - Refusal to participate in the study - Patients with a diagnosis of hematological malignancy - Patients with missing data required for research

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Preoperative nutritional assessment
Preoperative nutritional assessment and postoperative pulmonary complications

Locations

Country Name City State
Turkey Ankara Atatürk Sanatoryum Education and Research Hospital Ankara Keçioren

Sponsors (1)

Lead Sponsor Collaborator
Ankara Ataturk Sanatorium Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary FFMI - Fat-Free Mass Index FFMI is an abbreviation for lean mass index. It defines the amount of your muscle mass relative to height and weight. The FFMI is part of the well-known and similar BMI family of body indexes. The effect of FFMI values on postoperative patient stay, intensive care unit stay, complications and postoperative mobilization time in lung cancer patients will be evaluated. Each patient will be evaluated by measuring the preoperative FFMI value 24 hours before. 24 hours
Secondary BMI (Body Mass Index) BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass. The effect of BMI values on postoperative patient stay, intensive care unit stay, complications and postoperative mobilization time in lung cancer patients will be evaluated. Each patient will be evaluated by measuring the preoperative BMI value 24 hours before. 24 hours
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk